Article citationsMore>>

Bhatt, D.L., Steg, P.G., Miller, M., Brinton, E.A., Jacobson, T.A., Ketchum, S.B., Doyle Jr., R.T., Juliano, R.A., Jiao, L., Granowitz, C. and Tardif, J.C. (2019) Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. New England Journal of Medicine, 380, 11-22.
https://doi.org/10.1056/NEJMoa1812792

has been cited by the following article:

• TITLE: Omega-3 Fatty Acids and Risk of Atrial Fibrillation: A Case Report and Literature Review

  AUTHORS: Adnan M. A. Hajjiah, Zouheir I. Bitar Frcpuk, Ossama Sajeh Maadarani, Mohamad Abdelfatah

  KEYWORDS: Atrial Fibrillation, Omega-3, Food Supplements

  JOURNAL NAME: Open Journal of Internal Medicine, Vol.12 No.1, March 16, 2022

  ABSTRACT: Omega-3 fatty acids are one of the most used food supplements. However, atrial fibrillation has been recently presented as a rare adverse drug event following ingestion of high doses of this food supplement.